Form 4: DENTSPLY SIRONA Director Daniel Scavilla Granted 13,880 Restricted Stock Units

Sentiment:

Insider Transaction Report


DENTSPLY SIRONA Inc. Director Daniel T. Scavilla was granted 13,880 shares of common stock in the form of Restricted Stock Units (RSUs) on May 22, 2025, as part of a compensation package.

Summary

  • Daniel T. Scavilla, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 13,880 shares of common stock.
  • The acquisition occurred on May 22, 2025, and was a grant of Restricted Stock Units (RSUs) at a price of $0 per share.
  • These RSUs are scheduled to vest in full one year from the grant date, meaning restrictions will lapse on May 22, 2026.
  • Following this transaction, Mr. Scavilla beneficially owns a total of 17,265 shares of DENTSPLY SIRONA common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it represents a standard equity grant to a director, aligning their interests with shareholders, which is generally viewed favorably for corporate governance and long-term stability.

Positives

  • The grant of Restricted Stock Units (RSUs) to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
  • The vesting schedule encourages long-term commitment and retention of key personnel.

Future Outlook

The granted Restricted Stock Units (RSUs) are set to vest in full one year from the grant date, indicating that the shares will become fully owned by the director on May 22, 2026.

Industry Context

This Form 4 filing reflects a routine equity compensation event for a director, a common practice across various industries to incentivize and retain leadership by aligning their financial interests with the company's long-term performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation StructureGrant of 13,880 Restricted Stock Units (RSUs) to Director Daniel T. Scavilla as part of his compensation.05/22/2025This grant aligns the director's financial interests with the long-term performance of the company's stock, fostering shareholder value creation and retention.

Related Party Transactions

  • The transaction involves an equity grant from DENTSPLY SIRONA Inc. to Daniel T. Scavilla, a director of the company, which is a common form of related-party compensation.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the director's incentives with shareholder interests, potentially leading to better long-term performance.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • The Restricted Stock Units (RSUs) granted to Daniel T. Scavilla are expected to vest in full on May 22, 2026.

Key Dates

DateDescription
05/22/2025Date of transaction: Acquisition of 13,880 Restricted Stock Units (RSUs) by Daniel T. Scavilla.
05/27/2025Date the Form 4 was signed by the Attorney-in-Fact for Daniel T. Scavilla.

Keywords

DENTSPLY SIRONA, XRAY, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Beneficial Ownership, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.